A comparative study of galanthamine hydrobromide and atropine-neostigmine in conscious volunteers.
D000328:Adult; D001285:Atropine / Q000009:adverse effects / Q000494:pharmacology*; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004569:Electroencephalography; D004804:Eosinophils / Q000187:drug effects; D005260:Female; D005702:Galantamine / Q000009:adverse effects / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007958:Leukocyte Count; D009388:Neostigmine / Q000009:adverse effects / Q000494:pharmacology*; D013997:Time Factors
D001786:Blood Glucose; D002800:Cholinesterase Inhibitors; D005702:Galantamine; D009388:Neostigmine; D001285:Atropine